Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Thorium Compounds
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.
Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation.
A 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in women.
Viral infection: a potent barrier to transplantation tolerance.
See All 19 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Viral infection: a potent barrier to transplantation tolerance.
Miller DM, Thornley TB, Greiner DL, Rossini AA. Viral infection: a potent barrier to transplantation tolerance. Clin Dev Immunol. 2008; 2008:742810.
View in:
PubMed
subject areas
Animals
Graft Rejection
Humans
Immunity, Innate
Signal Transduction
Transplantation Immunology
Transplantation Tolerance
Virus Diseases
authors with profiles
Dale L Greiner PhD